In prostate cancer, the upregulation of isopeptidase ubiquitin-specific protease 2a (USP2a) after androgen stimulation, is shown to stabilize FASN expression by preventing ubiquitin-mediated degradation. This evidence concerns the gene FASN and Familial prostate cancer.